Regarding Recovery Support for Sri Lanka Following Damage from Cyclone Ditwa

TOKYO, Thursday December 25, 2025 -We pray for the repose of the souls of those who lost their lives in the torrential rains brought by Cyclone Ditwa, which made landfall in Sri Lanka at the end of November. We extend our deepest condolences to their bereaved families. We also hope for the swift rescue of those who are still missing. We offer our heartfelt sympathy to all those affected by this disaster.

Kirin Beverage Company, Limited hereby announces the following measures decided upon to support the affected areas:

The relationship between the Kirin Group and Sri Lanka goes beyond just the purchase of tea leaves. We collaborate on various initiatives, including supporting Sri Lankan tea plantations and improving working conditions. In light of this disaster, we are deeply concerned for those affected and will continue advancing efforts to support local recovery and livelihoods.
The Kirin Group will continue to provide appropriate additional support for recovery, working in collaboration with local plantations and related organisations, in response to the damage caused by Cyclone Ditwa, which struck at the end of November 2025.
We sincerely pray for the swiftest possible recovery and reconstruction of the affected areas.

About Kirin Holdings

Kirin Holdings Company, Limited is an international company that operates in the Food & Beverages domain (Food & Beverages businesses), Pharmaceuticals domain (Pharmaceuticals businesses), and Health Science domain (Health Science business), both in Japan and across the globe.

Kirin Holdings can trace its roots to Japan Brewery which was established in 1885. Japan Brewery became Kirin Brewery in 1907. Since then, the company expanded its business with fermentation and biotechnology as its core technologies, and entered the pharmaceutical business in the 1980s, all of which continue to be global growth centers. In 2007, Kirin Holdings was established as a pure holding company and is currently focusing on boosting its Health Science domain.

Under the Kirin Group Vision 2027 (KV 2027), a long-term management plan launched in 2019, the Kirin Group aims to become “A global leader in CSV* creating value across our world of Food & Beverages to Pharmaceuticals.” Going forward, the Kirin Group will continue to leverage its strengths to create both social and economic value through its businesses, with the aim of achieving sustainable growth in corporate value.

*: Creating Shared Value. Combined added value for consumers as well as for society at large.